Maximal Tolerated Dose I­-131 Therapy for Advanced Thyroid Cancer and Determination of Iodine Refractory Disease


Related Videos (117)

In patients with thyroid cancer, the thyroid can lose the capacity to concentrate iodine and become refractory to radioiodine therapy. In this video, Daniel Pryma, MD, considers the maximal tolerated dose of radioiodine in patients with advanced thyroid cancer, and describes the distinguishing features of true radioiodine-­refractory disease.


Penn PhysicianLink®

Penn PhysicianLink® is an exclusive program that helps all referring physicians connect with Penn Medicine. This comprehensive package of support services expedites and facilitates direct physician communication for patient consults, referrals and transfers.

Learn more about Penn PhysicianLink®